Conferences  >  Life Sciences  >  Biotechnology

The 2023 Gordon Research Conference on Chloroplast Biotechnology will present novel research in all areas relevant to engineering chloroplasts to either improve existing functions or provide them with new ones. The technologies discussed will cover the entire range from subtle tweaks in plastid metabolism to complete redesign of the plastid genome, and will include all aspects of modifying organellar genomes, proteomes or metabolomes needed for applications in agriculture, industrial biotechnology or the pharmaceutical sector.

Harnessing the SynBio Revolution for Metabolic Engineering and Enhanced Photosynthesis

The 2023 Advancing Gene Therapy conference will be held in Hyatt Regency Boston, MA. The meeting will provide conference attendees updates on recent gene therapy innovations from vector designs to product launch. Drivers of these advances will be discussed including the rapid pace of change from biotechnology, pharmaceutical, manufacturing and CROs with preclinical, non-clinical and trial expertise. In addition, the summit covers emerging and related fields including Gene Editing & CRISPR, Cell Therapies, Gene Therapy for Cancer, Immunotherapy, Rare diseases, Blood Disorders, Neurological Disorders, Toxicology Studies, advances in manufacturing, regulatory and medical affairs, Commercialization Strategies, Business Models and Market Access.

Pharmacogenomics, Personalized Medicine,    Stem-cell Research & Therapy

Students' Representation in Vilnius University Life Sciences Center

The COINS – International Conference of Life Sciences is organised entirely by students of Vilnius University. The event gathers various people working in the life sciences field – including students and scholars. We invite you to immerse yourself into a collaborative scientific experience, discuss, learn and share your thoughts with experts, expand your network and enjoy an exciting program.

This year, more than ever before, the conference will be dominated by presentations by the world's leading scientists on the practical application of research. During the conference, we will dive into biomedicine, bioengineering, neurobiology and ecology topics. Join us!

Executive Project Manager;     Email: executive@thecoins.eu

Biomedicine, Neurobiology, Ecology, Bioengineering, Cancer treatment, Molecular biology

Biology,    Molecular Biology

EBD Group

Spark the connections that will help establish partnerships with key leaders across the life science value chain. The inaugural Asia Bio Partnering Forum builds on the unrivalled success of its sister event ChinaBio® Partnering Forum. The event will take place in-person from April 26–27, 2023, in Singapore, and will convene biotech and pharma leaders from around the world with hundreds of emerging innovators across the Asia Pacific region to advance dealmaking in Asia.

The event will feature a blend of live and on-demand program sessions, company presentations, table-top exhibits, company showcases, partnering meetings and networking sessions. In keeping with EBD Group’s commitment to facilitate strategic connections that drive dealmaking, the event will also feature two days of digital partnering from May 4–5, 2023, hosted on partneringONE®. Digital partnering enables young biotech companies to gain valuable visibility and the opportunity to forge partnerships that move their research to the next level.

Customer Service;     Email: EBDcustomerservice@ebdgroup.com

partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, deal making, finance, investors, VCs, China, Asia, Asia-Pacific, life science

Fusion Conferences

Epigenetic mechanisms - including DNA and histone modifications, as well as regulation by non-coding RNAs - have pivotal roles in the nervous system. Aberrant epigenetic regulation also contributes to pathogenesis in various brain disorders. There are a number of recent ground-breaking discoveries of new features of epigenetic marks and regulation that are enriched in the nervous system, leading to an emerging new field of “neuroepigenetics”. In addition, new discoveries of modification of mRNAs and long non-coding RNAs lead to a new field of “epitranscriptomics”. This meeting will bring together experts and pioneers in studying neuroepigenetics and epitranscriptomics to provide an up-to-date and comprehensive picture of epigenetic and epitranscriptomic mechanisms in neural development, reprogramming and cell identity, plasticity, neuronal function and dysfunction. The meeting will offer opportunity for interdisciplinary interactions and future collaborations.

Molecular Biology,    Genomics and Bioinformatics

Cambridge healthtech Institute

Experience the Future of Biotherapeutic Drug Development Welcome to PEGS Boston The world’s largest gathering of protein engineering and biotherapeutics experts is back in Boston! PEGS Boston Summit is the leading biologics event with comprehensive programming covering all aspects of biologic drug development with in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytics, immunogenicity, and more. Harness the power of in-person events, form genuine connections, create valuable relationships with peers, and become part of the PEGS community.

Cambridge healthtech Institute;     Phone: [7819725400];     Email: reg@healthtech.com

Academic Research, Analytical Research, Big Data, Biochemical, Bioengineering, Bioinformatic, Biological Science, Biomedicine, Bioprocessing, Biopsy, Biosciences, Biotech, Biotechnology, Cancer Research, Cell, Data, Data Management, Data Science, Discovery, Diseases, Disorders, Drug, Expo, Gene, Health, Health & Medicine, Healthcare, Manufacturers, Medical, Medical Science, Medicine, Research, research symposium, Science, Science and Technology, Scientific, Stem Cell, Tissue Repair,

Regulation in Medicine and Pharmacology,    Pharmacogenomics, Personalized Medicine

Cambridge Healthtech Institute (CHI)

CHI announces final details for the 30th International Biodetection Technologies virtual conference on June 7-8, 2023. This internationally recognized meeting is for experts in detection & identification of biological threats. This 2-part event will address the key topics in detection and present the latest R&D and technological innovation in ready-to-market systems. In addition, this meeting focuses on the latest strategies to overcoming the hurdles to the identification of global biological threats and translational gaps in bringing technologies from lab to field. This virtual event will livestream on Eastern Daylight Time (EDT).

Phone: [+1 781-972-5400];     Email: jprudhomme@healthtech.com

biodetection technologies, biothreats, pathogens, point-of-care diagnostics, biosurveillance, diagnostics, infectious diseases, microbiology, sample preparation technologies

Society for In Vitro Biology

The Society for In Vitro Biology (SIVB) is heading to Norfolk, Virginia for the 2023 SIVB Annual Meeting for the first time ever and you can be part of it! Founded nearly 80 years ago as the Tissue Culture Association, the SIVB is fostering the exchange of knowledge of in vitro biology of cells, tissues, and organs from both the plant and animal kingdoms, including humans. The SIVB furthers biotechnology research to understand biology at the cellular and developmental level, and promotes, expands and supports the scientific knowledge base for the benefit of society as a whole. The scientific program will provide both state-of-the-art scientific research and core fundamentals presented by speakers you won’t want to miss. This year’s plenary topics include: Microbiomes, Product Development, Spatial Biology, Biotechnology for Sustainability, and Diversity in Science.

Phone: [910-755-5431];     Email: sivb@sivb.org

Biotechnology, gene editing, CRISPR, cell culture, tissue culture, organoid

Biology,    Genetics and genetic disorders

IMAPAC

Biologics Manufacturing Europe 2023 is the European region’s premier conference for the manufacturing community. This event connects the leaders of Biologics and Biosimilars Manufacturers to debate best practices in upstream and downstream bioprocessing.

Frankfurt, Germany will host this bioprocessing-focused, knowledge-sharing conference to provide regional biopharmaceutical industry stakeholders a carefully tailored networking platform for leveraging opportunities for strategic collaboration, and exposure to the latest manufacturing technologies and know-how. We have an agenda built around success stories from Europe's biopharmas as well as the technical expertise from International Biopharmas and BIG Pharmas, presentations on the latest manufacturing technologies such as single-use and end-to-end continuous processing for biologics, today’s challenges and opportunities in biomanufacturing, advances in upstream process development, cost-optimization strategies in downstream processing, analytical characterization strategies, facility design, and scale-up strategy, fill & finish innovation to streamline the operations amongst other crucial themes.

Marketing Executive;     Email: roxanne.chetty@imapac.com

Biologics, Biologics Manufacturing, Contract Manufacturing, Biotechnology, BME2023

Oxford Global Conferences

Join oligo leaders, experts and distinguished scientists in Europe, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations within the oligonucleotides chemistry & therapeutics development.

Phone: [+44 1865 248455];     Email: h.liddiard@oxfordglobal.co.uk

Oligonucleotides chemistry, biotechnology, oncology, Genetic disorders, Rare diseases, Infectious diseases, Cardiovascular diseases, Kidney diseases

Molecular Biology,    Oncology

Oxford Global Conferences

Learn from key opinion leaders working to deliver RNA therapies for several therapeutic areas including infectious disease and cardiovascular disease. Across two in-depth sessions the latest improvements pushing the industry forward will be addressed: from RNA formulation strategies, design and development through to antisense and oligo-mediated RNA delivery and improvements in extrahepatic delivery approaches.

Phone: [+44 1865 248455];     Email: h.liddiard@oxfordglobal.co.uk

RNA, Nanoparticles, Immunology, mMRA, Oligonucleotides

DECHEMA

The next ECCE/ECAB will take place as a face-to-face event from 17-21 September 2023 at the CityCube in Berlin/Germany. Make a note of this date in your calendar and look forward with us to interesting presentations, interactive exchange with colleagues, the diverse range of exhibitors and sponsors as well as a supporting programme that offers plenty of time for networking.

A - Green Deal – a common task for chemical and biochemical engineers; B - Chemical and Biochemical Engineering in Medicine; C - Acting Together - Biochemical and Chemical Engineering Integration; D - Matter in Motion; E - Faster and More Selective; F - Solid Matter; G - Tools and Toolkits for Chemical and biochemical reactors; H - Digital transformation; I - Early career programme

European Molecular Biology Laboratory | EMBL

This course will provide training in genome editing and cell engineering in mammalian cells and mouse embryos using the highly efficient CRISPR/Cas9 system. Participants will learn design of CRISPR targets using bioinformatics tools, generation of gene knock-outs/knock-ins, and target validation using the most current technologies.

Molecular Biology,    Genomics and Bioinformatics

Uventia Global

Highly potent active pharmaceutical ingredients, or HPAPIs, are potent compounds that could effectively treat serious and life-threatening diseases such as cancer. Because of their high potency, these substances eventually put the workers in the production facility at risk. While exceptional product quality is required, additional measures must be taken to ensure operator safety. At our online meeting, leading figures from the industry, occupational toxicologists and containment specialists will review the most recent developments affecting the handling of HPAPIs. The discussion will center on the safe and effective processing of potent APIs, process development and scale-up, occupational health hazards, toxicological assessment, improvements in isolators and facilities to minimize exposure risk, containment and cleaning validation practices, and risk management for cross-contamination.

Email: yuliia.terletska@uventia.com

HPAPI, API, Compounds Manufacturing, Occupational Toxicology, Industrial Hygiene, Process Engineering, Process Development, Containment, Cross Contamination, Cleaning Validation, Cleanroom, Risk Management, Quality Assurance, Quality Control, Analytical Development, Analytical Methods, Outsourcing

Biochemistry and Medicinal Chemistry, Toxicology,    Pharmacology and Drug Development

Oxford Global Conferences

Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine

Oxford Global Conferences;     Phone: [+44 1865 248455];     Email: b.westmore@oxfordglobal.co.uk

Biomarkers, Personalised Medicine, Oncology, Infectious Disorders, Imaging Technologies, Digital Pathology, Flow Cytometry, Immunoassays, Genomic Markers, Precision Medicine

The International Biotechnology Symposium Congress will be jointly organized with ECB, the Congress of European Federation of Biotechnology and with NBC, the annual Netherlands Biotechnology Conference, in Maastricht.

On behalf of the Dutch Biotechnology Association (NBV), we warmly welcome you to participate in this major world Biotechnology Congress in the beautiful city of Maastricht, the Netherlands. This will be a joint Congress, IBS2024 and ECB2024. The annual Netherlands Biotechnology Conference, NBC-24, as well as other highlight and satellite events from partners will complete the program. Since 1960, IBS2024 has been the major event organised by the biotechnology sub-division of IUPAC, the International Union of Pure and Applied Chemistry. ECB2024 is the 19th Congress organised by the European Federation of Biotechnology.